Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related ArticlesChoroideremia Research Is Necessary to Help Prevent Blindness at an Early Age National Eye Institute Awards $954,770 for a 5-Year Study on Lazy Eye Age-Related Macular Degeneration Happenings at the Foundation National Eye Institute Awards $949,804 for a 5-Year Study of RP What Does “Blindness” Really Mean?